Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,102 | -813 | -3,833 | -2,449 | -1,815 |
| Depreciation Amortization | 5 | 3 | 9 | 7 | 5 |
| Accounts receivable | -35 | 9 | 33 | -4 | -12 |
| Other Working Capital | 363 | 59 | 640 | 260 | 229 |
| Other Operating Activity | 63 | 5 | 89 | 110 | 96 |
| Operating Cash Flow | $-1,706 | $-738 | $-3,063 | $-2,076 | $-1,498 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | -2 | -3 | 0 |
| Other Investing Activity | 18 | 3 | 34 | 26 | 17 |
| Investing Cash Flow | $16 | $1 | $32 | $23 | $17 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,960 | N/A | 3,341 | 1,851 | 1,851 |
| Other Financing Activity | 0 | 75 | 0 | 585 | 0 |
| Financing Cash Flow | $1,960 | $75 | $3,341 | $2,436 | $1,851 |
| Beginning Cash Position | 1,271 | 1,271 | 960 | 960 | 960 |
| End Cash Position | 1,541 | 610 | 1,271 | 1,343 | 1,331 |
| Net Cash Flow | $270 | $-661 | $311 | $382 | $370 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,706 | -738 | -3,063 | -2,076 | -1,498 |
| Capital Expenditure | -2 | -2 | -7 | -8 | -4 |
| Free Cash Flow | -1,708 | -739 | -3,069 | -2,084 | -1,502 |